comparemela.com
  1. Home
  2. Live Updates
  3. Avistone Pharmaceuticals - Breaking News

Latest Breaking News On - Avistone pharmaceuticals - Page 2 : comparemela.com

Vivo Capital, Bain Back Chinese Biotech Firm in $200 Million Fundraising

Chinese biotechnology firm Avistone Pharmaceuticals has raised over $200 million in a series A round led by Vivo Capital in one of the largest such deals for the sector.

United statesHong kongPalo altoHongbo luHepeng shiAvistone pharmaceuticalsZai lab ltdPearl biotechnology coSinovac biotech ltdBolt biotherapeutics incVivo capitalBain capitalPrimavera capitalBeijing based avistonePearl biotechnologyGreater china

Vivo Capital Leads Investment in Avistone

Avistone develops on oncology therapies with a focus on treatments for lung cancer.

Jiaqi zhengHepeng shiAvistone pharmaceuticalsVivo capitalBain capitalPrimavera capital

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.